MustGrow Biologics Corp.
MGRO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.67% | 1,933.43% | 45.91% | 43.90% | -15.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.67% | 1,933.43% | 45.91% | 43.90% | -15.56% |
| Cost of Revenue | 1,018.51% | 1,196.13% | 1,196.06% | 1,017.53% | -3.18% |
| Gross Profit | 1,560.51% | 358.79% | -91.79% | -89.05% | -99.51% |
| SG&A Expenses | 29.68% | 36.77% | 26.21% | 19.50% | 4.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.23% | 99.84% | 82.50% | 64.86% | -1.88% |
| Operating Income | -16.88% | -18.65% | -2,890.06% | -6,670.94% | -2,152.46% |
| Income Before Tax | -24.78% | -40.38% | -2,330.37% | -1,049.19% | -612.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.78% | -40.38% | -2,330.37% | -1,049.19% | -612.82% |
| Earnings from Discontinued Operations | -70.16% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.98% | -45.72% | -2,436.37% | -1,106.26% | -649.02% |
| EBIT | -16.88% | -18.65% | -2,890.06% | -6,670.94% | -2,152.46% |
| EBITDA | -458.56% | -- | -- | -- | -- |
| EPS Basic | -15.42% | -37.63% | -3,822.73% | -1,178.69% | -628.57% |
| Normalized Basic EPS | -1.98% | -19.21% | -3,585.71% | -1,087.18% | -587.88% |
| EPS Diluted | -15.42% | -37.63% | -3,822.73% | -1,178.69% | -628.57% |
| Normalized Diluted EPS | -1.98% | -19.21% | -3,585.71% | -1,087.18% | -587.88% |
| Average Basic Shares Outstanding | 10.25% | 5.16% | 2.30% | 1.68% | 2.42% |
| Average Diluted Shares Outstanding | 10.25% | 5.16% | 2.30% | 1.68% | 2.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |